BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9210171)

  • 1. EEDQ reduces the striatal neurotensin mRNA response to haloperidol.
    Adams MR; Dobie DJ; Merchant KM; Unis A; Dorsa DM
    Peptides; 1997; 18(4):527-35. PubMed ID: 9210171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic haloperidol and clozapine treatment on neurotensin and c-fos mRNA in rat neostriatal subregions.
    Merchant KM; Dobie DJ; Filloux FM; Totzke M; Aravagiri M; Dorsa DM
    J Pharmacol Exp Ther; 1994 Oct; 271(1):460-71. PubMed ID: 7965747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-fos antisense oligonucleotide specifically attenuates haloperidol-induced increases in neurotensin/neuromedin N mRNA expression in rat dorsal striatum.
    Merchant KM
    Mol Cell Neurosci; 1994 Aug; 5(4):336-44. PubMed ID: 7804603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of muscimol on haloperidol-induced alteration of neurotensin gene expression in the striatum and nucleus accumbens in the rat.
    Decker KP; Roy-Byrne PP; Merchant KM
    Brain Res; 1995 Sep; 691(1-2):9-17. PubMed ID: 8590069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blunting of the neurotensin mRNA response to haloperidol in the striatum of aging rats: possible relationship to decline in dopamine D2 receptor expression.
    Dobie DJ; Merchant KM; Hamblin MW; Vatassery GT; Dysken MW; Dorsa DM
    Brain Res; 1993 Jul; 616(1-2):105-13. PubMed ID: 8358601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of serotonergic agents on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum.
    Ishikane T; Kusumi I; Matsubara R; Matsubara S; Koyama T
    Eur J Pharmacol; 1997 Feb; 321(2):163-9. PubMed ID: 9063684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of haloperidol and clozapine on neurotensin gene transcription in rat neostriatum.
    Merchant KM; Dobner PR; Dorsa DM
    J Neurosci; 1992 Feb; 12(2):652-63. PubMed ID: 1531499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration.
    Ward RP; Dorsa DM
    Neuroscience; 1999 Mar; 89(3):927-38. PubMed ID: 10199625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct and interactive effects of d-amphetamine and haloperidol on levels of neurotensin and its mRNA in subterritories in the dorsal and ventral striatum of the rat.
    Zahm DS; Williams ES; Krause JE; Welch MA; Grosu DS
    J Comp Neurol; 1998 Nov; 400(4):487-503. PubMed ID: 9786410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression of neurotensin and c-fos mRNAs in rat neostriatal neurons following acute haloperidol.
    Merchant KM; Miller MA
    Brain Res Mol Brain Res; 1994 May; 23(3):271-7. PubMed ID: 7914659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal dissociation of neurotensin/neuromedin N mRNA expression in topographically separate subsets of rat striatal neurons following administration of haloperidol.
    Zahm DS; Williams ES; Poulad D; Krause JE
    Brain Res Mol Brain Res; 1996 Nov; 42(1):71-8. PubMed ID: 8915582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of serotonergic drugs on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum].
    Ishikane T
    Hokkaido Igaku Zasshi; 1998 Sep; 73(5):441-9. PubMed ID: 9846274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex.
    Damask SP; Bovenkerk KA; de la Pena G; Hoversten KM; Peters DB; Valentine AM; Meador-Woodruff JH
    Brain Res Mol Brain Res; 1996 Sep; 41(1-2):241-9. PubMed ID: 8883957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desensitization and enhancement of neurotensin/neuromedin N mRNA responses in subsets of rat caudate-putamen neurons following multiple administrations of haloperidol.
    Zahm DS; Williams ES; Krause JE
    Brain Res Mol Brain Res; 1998 Aug; 59(2):196-204. PubMed ID: 9729381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurotensin antagonist SR 48692 attenuates haloperidol-induced striatal Fos expression in the rat.
    Fadel J; Dobner PR; Deutch AY
    Neurosci Lett; 2001 Apr; 303(1):17-20. PubMed ID: 11297813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics.
    Merchant KM; Dorsa DM
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3447-51. PubMed ID: 8097317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ritanserin on haloperidol-induced dopamine (D2) receptor up-regulation in the rat.
    Szczepanik AM; Wilmot CA
    Neurosci Lett; 1997 Aug; 231(2):91-4. PubMed ID: 9291148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of neurotensin and c-fos mRNA in distinct subregions of rat neostriatum after acute methamphetamine: comparison with acute haloperidol effects.
    Merchant KM; Hanson GR; Dorsa DM
    J Pharmacol Exp Ther; 1994 May; 269(2):806-12. PubMed ID: 8182549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of adenosine and N-methyl-D-aspartate receptors in mediating haloperidol-induced gene expression and catalepsy.
    Chartoff EH; Ward RP; Dorsa DM
    J Pharmacol Exp Ther; 1999 Nov; 291(2):531-7. PubMed ID: 10525068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
    Morissette M; Lévesque D; Di Paolo T
    Mol Pharmacol; 1992 Sep; 42(3):480-8. PubMed ID: 1357544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.